EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 340 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,311,535 | +59.9% | 126,596 | +82.2% | 0.02% | +60.0% |
| Q4 2022 | $820,394 | -60.2% | 69,466 | -29.2% | 0.01% | -64.3% |
| Q3 2022 | $2,059,000 | -23.1% | 98,079 | +13.6% | 0.03% | -17.6% |
| Q2 2022 | $2,679,000 | -24.4% | 86,320 | +0.0% | 0.03% | -10.5% |
| Q1 2022 | $3,543,000 | -8.8% | 86,299 | -3.5% | 0.04% | -2.6% |
| Q4 2021 | $3,886,000 | +3.2% | 89,395 | +18.8% | 0.04% | +5.4% |
| Q3 2021 | $3,766,000 | -18.4% | 75,221 | +2.7% | 0.04% | -19.6% |
| Q2 2021 | $4,614,000 | -49.7% | 73,245 | -25.8% | 0.05% | -52.1% |
| Q1 2021 | $9,174,000 | -1.0% | 98,745 | -4.5% | 0.10% | -8.6% |
| Q4 2020 | $9,262,000 | -14.3% | 103,367 | -1.2% | 0.10% | -27.1% |
| Q3 2020 | $10,811,000 | +3.3% | 104,625 | -20.9% | 0.14% | -2.7% |
| Q2 2020 | $10,462,000 | +27.2% | 132,300 | -6.9% | 0.15% | +7.2% |
| Q1 2020 | $8,222,000 | +42.0% | 142,093 | +32.4% | 0.14% | +86.5% |
| Q4 2019 | $5,791,000 | -41.0% | 107,349 | -42.9% | 0.07% | -46.0% |
| Q3 2019 | $9,821,000 | +12.4% | 187,850 | +3.8% | 0.14% | +10.5% |
| Q2 2019 | $8,741,000 | +17.9% | 180,945 | +23.3% | 0.12% | +14.8% |
| Q1 2019 | $7,415,000 | -13.7% | 146,769 | +1.2% | 0.11% | -23.9% |
| Q4 2018 | $8,594,000 | -10.5% | 144,976 | -0.6% | 0.14% | +4.4% |
| Q3 2018 | $9,597,000 | +45.9% | 145,787 | +11.9% | 0.14% | +38.8% |
| Q2 2018 | $6,576,000 | -4.2% | 130,237 | -0.1% | 0.10% | -7.5% |
| Q1 2018 | $6,866,000 | +13.1% | 130,401 | -0.2% | 0.11% | +14.0% |
| Q4 2017 | $6,070,000 | +17.9% | 130,615 | +2.6% | 0.09% | +10.7% |
| Q3 2017 | $5,149,000 | +20.5% | 127,290 | +1.0% | 0.08% | +13.5% |
| Q2 2017 | $4,273,000 | +13.1% | 126,003 | -3.1% | 0.07% | +10.4% |
| Q1 2017 | $3,777,000 | -38.1% | 130,058 | -29.9% | 0.07% | -41.7% |
| Q4 2016 | $6,097,000 | -5.8% | 185,661 | -9.5% | 0.12% | -11.5% |
| Q3 2016 | $6,469,000 | +12.3% | 205,156 | +0.1% | 0.13% | +5.7% |
| Q2 2016 | $5,763,000 | -22.2% | 204,941 | +0.6% | 0.12% | -25.0% |
| Q1 2016 | $7,408,000 | -9.6% | 203,789 | -0.6% | 0.16% | -10.9% |
| Q4 2015 | $8,199,000 | +43.6% | 204,919 | +2.3% | 0.18% | +36.3% |
| Q3 2015 | $5,709,000 | -13.6% | 200,380 | -0.1% | 0.14% | -6.9% |
| Q2 2015 | $6,607,000 | +43.8% | 200,505 | +25.5% | 0.14% | +45.0% |
| Q1 2015 | $4,595,000 | +2.7% | 159,785 | -2.8% | 0.10% | -1.0% |
| Q4 2014 | $4,476,000 | +29.9% | 164,384 | +1.6% | 0.10% | +23.2% |
| Q3 2014 | $3,447,000 | -5.1% | 161,776 | 0.0% | 0.08% | -3.5% |
| Q2 2014 | $3,633,000 | +7.7% | 161,776 | +21.2% | 0.08% | +3.7% |
| Q1 2014 | $3,373,000 | +14.8% | 133,490 | +4.5% | 0.08% | +13.9% |
| Q4 2013 | $2,938,000 | +73.0% | 127,790 | +43.4% | 0.07% | +56.5% |
| Q3 2013 | $1,698,000 | +35.5% | 89,123 | +2.6% | 0.05% | +24.3% |
| Q2 2013 | $1,253,000 | – | 86,875 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
| Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
| AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
| Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
| EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
| SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
| Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
| AtonRa Partners | 11,505 | $472,000 | 0.26% |